Login Register Cart 0
Generic placeholder image

Recent Patents on Nanotechnology

Editor-in-Chief

ISSN (Print): 1872-2105
ISSN (Online): 2212-4020

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspective

Hybrid Nanophotonic Graphene Systems: A Transformative Innovation for Transdermal Drug Delivery

Author(s): Dilpreet Singh* and Mandavi Pandey

Volume 19, Issue 2, 2025

Published on: 22 September, 2024

Page: [160 - 165] Pages: 6

DOI: 10.2174/0118722105329862240919075834

Abstract

Transdermal Drug Delivery Systems (TDDSs) offer non-invasive administration and sustained drug release, enhancing patient compliance. However, the skin's natural barrier, particularly the stratum corneum, limits the effectiveness of TDDS for high molecular weight and hydrophilic substances. Innovations in material science, particularly hybrid nanophotonic graphene systems, present promising solutions. Nanophotonics generate localized photothermal effects to create microchannels in the skin, while graphene enhances permeability through its electrical and thermal conductivity. Hybrid nanophotonic systems, such as photonic crystals, plasmonic nanoparticles, metamaterials, quantum dots, nanowires, fiber optic nanosensors, and nanoantennas, offer precise control and real-time monitoring for applications in cancer therapy, chronic pain management, targeted drug delivery, and personalized medicine. This perspective examines the design, effectiveness, biocompatibility, and clinical implications of these hybrid systems, highlighting their potential to expand transdermal drug delivery and revolutionize treatment in personalized medicine. This particular formulation holds patentability, as supported by product patents that highlight the advancements in hybrid nanophotonic graphene systems for transdermal drug delivery.

Keywords: Nanophotonics, graphene, transdermal drug delivery, photothermal effects, electroporation, personalized medicine.

« Previous Next »
Graphical Abstract

[1]
Fan X, Jiao G, Gao L, Jin P, Li X. The preparation and drug delivery of a graphene–carbon nanotube–Fe3O4 nanoparticle hybrid. J Mater Chem B Mater Biol Med 2013; 1(20): 2658-64.
[http://dx.doi.org/10.1039/c3tb00493g] [PMID: 32260953]
[2]
Jin J, Guo M, Liu J, et al. Graphdiyne nanosheet-based drug delivery platform for photothermal/chemotherapy combination treatment of cancer. ACS Appl Mater Interfaces 2018; 10(10): 8436-42.
[http://dx.doi.org/10.1021/acsami.7b17219] [PMID: 29457450]
[3]
Mohamed AT, Hameed RA, EL-Moslamy SH, et al. Facile synthesis of Fe2O3, Fe2O3@CuO and WO3 nanoparticles: Characterization, structure determination and evaluation of their biological activity. Sci Rep 2024; 14(1): 6081.
[http://dx.doi.org/10.1038/s41598-024-55319-8] [PMID: 38480834]
[4]
Othman MS, Obeidat ST, Al-Bagawi AH, Fareid MA, Fehaid A, Abdel Moneim AE. Green-synthetized selenium nanoparticles using berberine as a promising anticancer agent. J Integr Med 2022; 20(1): 65-72.
[http://dx.doi.org/10.1016/j.joim.2021.11.002] [PMID: 34802980]
[5]
Mo R, Jiang T, Sun W, Gu Z. ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery. Biomaterials 2015; 50: 67-74.
[http://dx.doi.org/10.1016/j.biomaterials.2015.01.053] [PMID: 25736497]
[6]
Wang C, Zhang Z, Chen B, Gu L, Li Y, Yu S. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system. J Colloid Interface Sci 2018; 516: 332-41.
[http://dx.doi.org/10.1016/j.jcis.2018.01.073] [PMID: 29408121]
[7]
Qureshi MT, Tehseen A, Iqbal T, et al. Enhanced photocatalytic efficiency and biosensing in plasmonic nanostructures for the detection of bacteria in various analytes. Opt Quantum Electron 2023; 55(13): 1147.
[http://dx.doi.org/10.1007/s11082-023-05345-z]
[8]
Abdel Hameed R, Faride M, Othman M, et al. Green synthesis of zinc sulfide nanoparticles-organic heterocyclic polyol system as eco-friendly anti corrosion and anti-bacterial corrosion inhibitor for steel in acidic environment. Green Chem Lett Rev 2022; 15(3): 847-62.
[http://dx.doi.org/10.1080/17518253.2022.2141585]
[9]
Weaver CL, LaRosa JM, Luo X, Cui XT. Electrically controlled drug delivery from graphene oxide nanocomposite films. ACS Nano 2014; 8(2): 1834-43.
[http://dx.doi.org/10.1021/nn406223e] [PMID: 24428340]
[10]
Ruiyi L, Zaijun L, Xiulan S, et al. Graphene quantum dot-rare earth upconversion nanocages with extremely high efficiency of upconversion luminescence, stability and drug loading towards controlled delivery and cancer theranostics. Chem Eng J 2020; 382: 122992.
[http://dx.doi.org/10.1016/j.cej.2019.122992]
[11]
Othman MS, Obeidat ST, Aleid GM, et al. Green synthetized selenium nanoparticles using Syzygium aromaticum (clove) extract reduce pentylenetetrazol-induced epilepsy and associated cortical damage in rats. Appl Sci (Basel) 2023; 13(2): 1050.
[http://dx.doi.org/10.3390/app13021050]
[12]
Chen Y, Yang Y, Xian Y, et al. Multifunctional graphene-oxide-reinforced dissolvable polymeric microneedles for transdermal drug delivery. ACS Appl Mater Interfaces 2020; 12(1): 352-60.
[PMID: 31825580]
[13]
Justin R, Chen B. Strong and conductive chitosan–reduced graphene oxide nanocomposites for transdermal drug delivery. J Mater Chem B Mater Biol Med 2014; 2(24): 3759-70.
[http://dx.doi.org/10.1039/c4tb00390j] [PMID: 32261722]
[14]
Tang X, Chen Z, Chen Y, et al. Hybrid bismuth oxide-graphine oxide nanomaterials improve the signal-to-noise response of small molecules analyzed by matrix assisted laser desorption ionization-time-of-flight mass spectrometry. Talanta 2023; 252: 123768.
[http://dx.doi.org/10.1016/j.talanta.2022.123768] [PMID: 36030736]
[15]
Sattar T. Current review on synthesis, composites and multifunctional properties of graphene. Top Curr Chem (Cham) 2019; 377(2): 10.
[http://dx.doi.org/10.1007/s41061-019-0235-6] [PMID: 30874921]
[16]
Dai H, Liu Z, Li X, Sun X. Transdermal drug delivery using graphene-based materials. U.S. Patent (US9,233,166 B2), 2016.
[17]
Choi M, Kim KG, Heo J, Jeong H, Kim SY, Hong J. Multilayered graphene nano-film for controlled protein delivery by desired electro-stimuli. Sci Rep 2015; 5(1): 17631.
[http://dx.doi.org/10.1038/srep17631] [PMID: 26621344]
[18]
Dai H, Liu Z, Li X, Sun X. Supramolecular functionalization of graphitic nanoparticles for drug delivery. U.S. Patent (US 8,535,726 B2), 2013.
[19]
Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater 2013; 9(12): 9243-57.
[http://dx.doi.org/10.1016/j.actbio.2013.08.016] [PMID: 23958782]
[20]
Su YL, Chen KT, Sheu YC, et al. The penetrated delivery of drug and energy to tumors by lipo-graphene nanosponges for photolytic therapy. ACS Nano 2016; 10(10): 9420-33.
[http://dx.doi.org/10.1021/acsnano.6b04414] [PMID: 27684199]
[21]
Nel AE, Meng H, Mei KC. Nano-enabled immunotherapy in cancer. U.S. Patent (US20230241244 A1), 2023.
[22]
Tanimola OW. Transdermal drug delivery system. U.S. Patent 11,479,466,(US 11,479,466 B2), 2022.
[23]
Shah RN, Jakus AE, Hersam MC, Secor EB. Graphene-based ink compositions for three-dimensional printing applications. U.S. Patent (US 10,350,329 B2), 2019.
[24]
Harris TJ, Kim AAC. Transdermal drug delivery system. U.S. Patent (US 20200155681 B2), 2020.
[25]
Shankman RS. Facile synthesis of graphene, graphene derivatives and abrasive nanoparticles and their various uses, including as tribologically-beneficial lubricant additives. CA Patent (CA2857947C), 2015.

Rights & Permissions Print Cite
Article Metrics
15
2
Wayfinder Image
© 2025 Bentham Science Publishers | Privacy Policy